Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with MASLD (a type of liver condition related to fat buildup)
- People who also have type 2 diabetes (confirm with trial site for full details on this criterion)
- Healthcare providers (doctors, physician assistants, and nurse practitioners) who are delivering primary care during the intervention phase of the study may also be included as participants in a survey component
Who may not be able to join:
- People who have cirrhosis (severe liver scarring) or complications related to cirrhosis, such as high blood pressure in the liver's blood vessels or confusion caused by liver problems
- People who have liver cancer (hepatocellular carcinoma)
- People who have previously had a liver transplant
- People who are currently pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Andrew Schreiner, MD, MSCR, Medical University of South Carolina
Phone: (843) 876-0888
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Detection of advanced fibrosis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.